Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Device Simplifies Identification of Leishmania Hosts

By LabMedica International staff writers
Posted on 22 May 2017
Researchers have developed a novel device for obtaining essentially painless, minimally invasive microbiopsies (MBs) that mimic sand fly bites and meals, providing a convenient sampling method for identifying asymptomatic, potentially infectious carriers of Leishmania donovani in endemic areas.

Leishmania donovani species, parasites that cause visceral leishmaniasis (VL), are transmitted to humans by phlebotomine sandflies infected from a blood (+skin) meal taken upon biting an infected reservoir host animal – mainly humans (India and East Africa) or dogs (Latin America, Europe, Middle East, and North Africa). More...
The majority of infected individuals remains asymptomatic, but serve as parasite reservoirs for transmission of the disease via sandflies. The gold standard for assessing infectiousness of human hosts to biting vector insects is xenodiagnosis – scoring infection rates among insectary-reared insects that had fed on humans suspected of being infected. However, when it comes to sandflies and leishmaniasis, xenodiagnosis is an intricate operation burdened by logistical hurdles and ethical concerns that prevent its effective application for population screening.

An international research team from Australia, Ethiopia, Israel, and USA, led by Alon Warburg, professor at Hebrew University Hadassah Medical School, has developed and tested minimally invasive microbiopsy (MB) devices designed to penetrate the skin to a depth of ∼200µm and absorb blood as well as skin cell lysates, mimicking the “pool-feeding” mode by which the sandflies acquire blood meals.

Using the devices, MBs taken from 137 of 262 volunteers in endemic VL foci in Ethiopia detected Leishmania parasites that could potentially be imbibed by sandflies upon feeding. Although the volume of MB samples was 10-fold smaller than finger-prick blood samples, Leishmania DNA detection rates from MBs were significantly higher, implying that skin, more often than blood, was the main source of parasites.

Volunteers with histories of VL were almost as likely as healthy volunteers to test positive by MBs, suggesting the importance of asymptomatic people as reservoir hosts. These MB devices could enable to reliably and efficiently assess both L. donovani infection rates among large numbers of asymptomatic carriers and their infectiousness to blood-feeding sandflies.

The study, by Kirstein OD et al, was published April 26, 2017, in the International Journal for Parasitology.


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Alcohol Testing Device
Dräger Alcotest 7000
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.